A validated UHPLC-MS/MS method for rapid determination of senicapoc in plasma samples

The clinically tested KCa3.1 channel blocker, senicapoc, has been proven to have excellent pharmacological properties and prior clinical trials found it to be safe for use in patients with sickle cell anaemia. Currently, several preclinical projects are aiming to repurpose senicapoc for other indica...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Pharm Biomed Anal
Main Authors: Sørensen, Lambert K., Petersen, Asbjørn, Granfeldt, Asger, Simonsen, Ulf, Hasselstrøm, Jørgen B.
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier B.V. 2021
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7869607/
https://ncbi.nlm.nih.gov/pubmed/33626443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpba.2021.113956
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker